Consistent with our finding of the increased expression of these markers, at least in part, similar changes in the adipose tissue expression of MyD88, IRF3, NF-κB, and AML1 have been reported in obesity and/or T2D [28,29,66]. Here, IRF3 is linked to type 2 diabetes mellitus.